Current medical research and opinion
The most recent articles from:
Curr Med Res Opin
-
Review Comparative Study
Systematic review of tapentadol in chronic severe pain.
A systematic review of chronic pain treatment with strong opioids (step 3 WHO pain ladder) and a comparison to a new drug recently approved for the treatment of severe chronic pain in Europe, tapentadol (Palexia, Nucynta*), were performed. ⋯ Taken together, the benefit-risk ratio of tapentadol appears to be improved compared to step 3 opioids.